12 Health Care Stocks Moving In Monday's After-Market Session

Gainers

  • Biophytis BPTS stock moved upwards by 15.8% to $0.95 during Monday's after-market session. The company's market cap stands at $15.5 million.
  • Lyra Therapeutics LYRA stock moved upwards by 8.81% to $5.8. The market value of their outstanding shares is at $184.5 million.
  • Checkpoint Therapeutics CKPT shares moved upwards by 8.25% to $1.18. The market value of their outstanding shares is at $107.4 million.
  • Tivic Health Systems TIVC shares rose 8.17% to $2.25. The market value of their outstanding shares is at $21.6 million.
  • SELLAS Life Sciences Gr SLS shares moved upwards by 6.55% to $2.6. The market value of their outstanding shares is at $53.3 million.
  • Celcuity CELC stock rose 6.48% to $9.85. The company's market cap stands at $147.1 million.

Losers

  • SINTX Technologies SINT shares fell 9.7% to $0.41 during Monday's after-market session. The market value of their outstanding shares is at $10.0 million.
  • Roivant Sciences ROIV stock fell 8.41% to $3.87. The market value of their outstanding shares is at $2.7 billion.
  • Nymox Pharmaceutical NYMX stock declined by 6.67% to $0.27. At the close, Nymox Pharmaceutical's trading volume reached 62.5K shares. This is 15.0% of its average volume over the last 100 days. The company's market cap stands at $24.0 million.
  • Vyant Bio VYNT stock decreased by 5.15% to $0.83. The company's market cap stands at $24.4 million.
  • Corbus Pharmaceuticals CRBP shares fell 4.98% to $0.28. The company's market cap stands at $35.1 million.
  • Nuvation Bio NUVB stock fell 4.93% to $3.28. The market value of their outstanding shares is at $718.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!